Aberrant E-cadherin Expression in Invasive Ductal and Mixed Ductal–Lobular Breast Carcinomas
Anticancer Research · 2026-08 · 46 (8) · 4345-4356
DOI: 10.21873/anticanres.18292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Yumin Chung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Cadherins, Carcinoma, Ductal, Breast, Breast Neoplasms, Carcinoma, Lobular.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea hyun-soo.kim@samsung.com.
- Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; sungim.do@samsung.com.
Zitieren
APA
Chung, Y., Kim, H. S., & DO, S. I. (2026). Aberrant E-cadherin Expression in Invasive Ductal and Mixed Ductal–Lobular Breast Carcinomas. Anticancer Research, 46(8), 4345-4356. https://doi.org/10.21873/anticanres.18292
Vancouver
Chung Y, Kim HS, DO SI. Aberrant E-cadherin Expression in Invasive Ductal and Mixed Ductal–Lobular Breast Carcinomas. Anticancer Research. 2026;46(8):4345-4356. doi:10.21873/anticanres.18292
BibTeX
@article{Chung2026,
author = {Chung, Yumin and Kim, Hyun-Soo and DO, Sung-Im},
title = {Aberrant E-cadherin Expression in Invasive Ductal and Mixed Ductal–Lobular Breast Carcinomas},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {8},
pages = {4345--4356},
doi = {10.21873/anticanres.18292}
}
EUVIMED